Skip to content

VSee Health, Inc.: 10-Q filed 2024-09-23

What VSee Health, Inc. reported in its quarterly report filed 2024-09-23 (fiscal Q2 2024): 44 published measures, 125 facts as tagged in accession 0001558370-24-012936.

This filing

Form
10-Q (quarterly report)
Filed
2024-09-23
Fiscal period
fiscal Q2 2024
Accession
0001558370-24-012936 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VSee Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-06-3078,987,750USD
At 2023-12-31830,791USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-06-3024,177,194USD
At 2023-12-314,243,438USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-06-301,105,971USD
At 2023-12-31118,734USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-329,981USD91
2024-01-01 to 2024-06-30-332,792USD182
2024-01-01 to 2024-03-31-2,811USD91
2023-04-01 to 2023-06-30-424,610USD91
2023-01-01 to 2023-06-30-875,862USD181
2023-01-01 to 2023-03-31-451,252USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-2,594,214USD182
2023-01-01 to 2023-06-30-474,643USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-06-3045,513USD182
2023-01-01 to 2023-06-302,690USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,711,566USD91
2024-01-01 to 2024-06-303,207,561USD182
2023-04-01 to 2023-06-301,290,223USD91
2023-01-01 to 2023-06-302,886,491USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-06-303,597,841USD182
2023-01-01 to 2023-06-30320,000USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-16,390USD182
2023-01-01 to 2023-06-30-2,690USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-06-30-9,773,056USD
At 2023-12-31-9,114,985USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-04-01 to 2024-06-305,302,490shares91
2024-01-01 to 2024-06-304,971,066shares182
2023-04-01 to 2023-06-304,639,643shares91
2023-01-01 to 2023-06-304,639,643shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-04-01 to 2024-06-305,302,490shares91
2024-01-01 to 2024-06-304,971,066shares182
2023-04-01 to 2023-06-304,639,643shares91
2023-01-01 to 2023-06-304,639,643shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.06USD/shares91
2024-01-01 to 2024-06-30-0.07USD/shares182
2023-04-01 to 2023-06-30-0.09USD/shares91
2023-01-01 to 2023-06-30-0.19USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-0.06USD/shares91
2024-01-01 to 2024-06-30-0.07USD/shares182
2023-04-01 to 2023-06-30-0.09USD/shares91
2023-01-01 to 2023-06-30-0.19USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-2,241,208USD91
2024-01-01 to 2024-06-30-2,241,208USD182
2023-04-01 to 2023-06-30-174,395USD91
2023-01-01 to 2023-06-30-357,238USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-06-30883,323USD
At 2023-12-313,657USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-1,183,342USD91
2024-01-01 to 2024-06-30-1,144,863USD182
2023-04-01 to 2023-06-30-611,127USD91
2023-01-01 to 2023-06-30-1,248,272USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-06-305,166,549USD
At 2023-12-31827,134USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-06-3022,879,867USD
At 2023-12-314,243,438USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2024-06-3059,900,694USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-06-302,513,855USD
At 2023-12-31628,480USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-04-01 to 2024-06-302,408,268USD91
2024-01-01 to 2024-06-303,479,531USD182
2023-04-01 to 2023-06-301,427,063USD91
2023-01-01 to 2023-06-303,085,154USD181

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,224,926USD91
2024-01-01 to 2024-06-302,334,668USD182
2023-04-01 to 2023-06-30815,936USD91
2023-01-01 to 2023-06-301,836,882USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-3014,806,820shares
At 2024-06-2514,692,820shares
At 2024-06-2414,692,820shares
At 2023-12-314,639,643shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-06-301,105,971USD
At 2023-12-31118,734USD
At 2023-06-3073,331USD
At 2022-12-31230,664USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-06-3064,582,130USD
At 2023-12-316,027,153USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2024-06-3054,810,556USD
At 2024-03-31-3,383,478USD
At 2023-12-31-3,412,647USD
At 2023-06-30-886,633USD
At 2023-03-31-458,052USD
At 2022-12-31-2,033USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-06-30691,684USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-06-30694,417USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2024-06-302,428,880USD
At 2023-12-31220,000USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2024-06-30889,632USD
At 2023-12-314,335USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2024-06-306,309USD
At 2023-12-31678USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2024-06-3012,100,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-06-30760,789USD
At 2023-12-3179,920USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2024-06-301,023,492USD
At 2023-12-31802,524USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-2,603,169USD91
2024-01-01 to 2024-06-30-2,574,000USD182
2023-04-01 to 2023-06-30-602,976USD91
2023-01-01 to 2023-06-30-1,241,838USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-361,961USD91
2024-01-01 to 2024-06-30-332,792USD182
2023-04-01 to 2023-06-30-428,581USD91
2023-01-01 to 2023-06-30-884,600USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-04-01 to 2024-06-30509,050USD91
2024-01-01 to 2024-06-30660,398USD182
2023-04-01 to 2023-06-30326,386USD91
2023-01-01 to 2023-06-30607,639USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-04-01 to 2024-06-301,473USD91
2024-01-01 to 2024-06-302,091USD182
2023-04-01 to 2023-06-30157USD91
2023-01-01 to 2023-06-30204USD181

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-04-01 to 2024-06-30349,695USD91
2024-01-01 to 2024-06-30359,005USD182
2023-04-01 to 2023-06-3079,860USD91
2023-01-01 to 2023-06-30127,262USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-04-01 to 2024-06-30-1,419,827USD91
2024-01-01 to 2024-06-30-1,429,137USD182
2023-04-01 to 2023-06-308,151USD91
2023-01-01 to 2023-06-306,434USD181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-2,336,506USD182
2023-01-01 to 2023-06-30-357,236USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2024-01-01 to 2024-06-302,772USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-216,774USD182
2023-01-01 to 2023-06-30107,254USD181

Inspect the source

Entity
VSee Health, Inc. / CIK 0001864531
Captured
2026-09-21T17:39:21.273Z
SEC response SHA-256
6642e74f95af94f3060ba6cc0c814e9b3850bf810da50632789baa03a078bbe4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001864531.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))